From “High Potential for Abuse” to “Accepted Medical Use”: Tracking Developments and Possible Outcomes of Federal Cannabis Rescheduling in the U.S. | JD Supra
Whether you believe that cannabis legalization has occurred too quickly or too slowly, one thing is certain: recent developments herald a potentially...
Survey: 32% of Cannabis Consumers Would Return to Illicit Market If Schedule III Limits Access - Ganjapreneur
About one-third (32%) of cannabis consumers say that if a rescheduling action were to restrict the industry by requiring retail sales to be prescription-based
One-Third Of Marijuana Consumers Would Return To Illicit Market If Rescheduling Restricts Access To Pharmacies, New Poll Finds
About one-third of marijuana consumers say they would go back to the illicit market if cannabis was rescheduled and only made legally available as a Food and Drug Administration- (FDA) approved prescription drug, according to a new poll. As federal agencies work to complete an administrative review into cannabis scheduling, the survey from Nugg MD […]
Why Some Activists Fear Marijuana Rescheduling: Responding To Former FDA Official’s Dismissal Of Our Concerns (Op-Ed)
“This is the Judgment Day that we all predicted while sharing a conspiratorial joint in the dark days of prohibition. It’s surreal to see our fears manifesting in real time.” By Deb Tharp, NuggMD Politico recently published an extensive Q&A with Howard Sklamberg, a former top Food and Drug Administration (FDA) official who currently works […]
Personal View: How Ohio can suppress the cannabis black market | Crain's Cleveland Business
'Lawmakers can incentivize communities to include legal recreational dispensaries so black market purveyors can't rush in to fill the void,' writes the head of legal and policy research at NuggMD, a telehealth company for cannabis.
The Ohio Senate Republican bill on legal cannabis is a trick - Ohio Capital Journal
The Ohio Senate's attempt to rewrite the legal cannabis law passed by voters includes wins on accelerated adult-use sales and expungement, but beyond that is a giveaway to cops and to county jail administrators at the expense of social equity, writes NuggMD head of legal and policy research Deb Tharp.
We know legal cannabis will drive tax revenue. The question is, what will Ohio legislators allow it to pay for? Andrew Graham
On Issue 2, Ohioans voted to end cannabis prohibition largely because they were disgusted with the racial targeting and excessive incarceration it has caused. Yet state Republicans are set to respond by stealing money from the weed piggy bank and using it to pay for more racial targeting and excessive incarceration, writes guest columnist Andrew Graham, head of communications at NuggMD, the telehealth platform for cannabis that operates in 25 states where medical cannabis is lawful, including Ohio.
66% of Ohio cannabis users plan to buy recreational marijuana legally if Issue 2 passes - Ohio Capital Journal
A majority of cannabis users in Ohio plan to buy recreational marijuana legally, even if it’s more expensive than the black market, according to a new poll.
420 with CNW — Survey Shows Patients Satisfied with Marijuana as Neuropathy Treatment - CannabisNewsWire
A recent survey has found that marijuana is equally effective in alleviating neuropathy symptoms as opioids, raising questions about the validity of previous studies that utilized government-grown cannabis with lower potency. The survey was conducted by NuggMD, a company that connects patients with medical marijuana recommendations, and it involved 603 participants who used marijuana primarily … Continue reading "420 with CNW — Survey Shows Patients Satisfied with Marijuana as Neuropathy Treatment"
Previous research has indicated that cannabis and cannabinoids hold a number of potential neurological benefits, and new research is reinforcing that notion, specifically when it comes to neuropathy.
Cannabis Offers Sustained Relief for Neuropathic Pain Patients
Neuropathic pain is typically caused by an ongoing, progressive nerve disease. However, neuropathic pain can also result after a patient experiences an
8/25: Pay More, Get Less: The SAFE Banking Act Overpromises and Under Delivers
One would think that there would be consensus among lawmakers to step up and support an industry that has enormous bipartisan popularity and adds to state tax revenue. But that is not the case.
8/24: Patients Say Marijuana Treats Neuropathy Just As Well As Opioids, And Most Report Using High-THC Cannabis, New Survey Finds
Marijuana is just as effective at treating symptoms of neuropathy as opioids are, according to the results of a new survey. And what’s more, the majority of patients with the often-painful condition say they’re using cannabis with more than 20 percent THC, raising questions about the quality of prior studies that relied on government-grown marijuana […]
8/15: Op-ed: Enforcement alone will not solve New York's gray market weed problem | Crain's New York Business
Policymakers need to focus on educating the public about why legal cannabis is superior to gray market product, writes NuggMD co-founder Alex Milligan.
6/14: Only More Licensed Stores Will Solve New York’s Gray Market Pot Problem
Legal cannabis on sale in New York (photo: John McCarten NYC Council Media Unit)
Law-enforcement sources, anti-gentrification community boards, and othe...
5/9: Industry Voices—SAMHSA wants to exempt buprenorphine from the Ryan Haight Act. It should chart the same course for cannabis once it's rescheduled
Both cannabis and buprenorphine have been used to treat opiate addiction, and both have been prescribed or recommended for this purpose via telemedicine during the pandemic. | Cannabis's reclassification will have far-reaching unintended consequences on already-established state medical marijuana markets. We can reduce this chaos by implementing self-enacting regulations that will foresee and forestall these potential disruptions.
4/20: We Asked Experts What You Should Do If You Overdose On Weed
"Alex Milligan, cofounder and CMO of NuggMD, the US’s largest cannabis telemedicine company, announced the use of Too High Hotline for people who want to learn more about cannabis products or are in the midst of unpleasant effects."
4/17: Marijuana’s First Analyst Talks About Prices, Financing and Black Markets
For this week’s edition, Bloomberg News consumer editor Jonathan Roeder spoke with cannabis analyst Vivien Azer, who offered her perspectives on low marijuana prices, the banking crunch following SVB’s crash and how states are doing in their legalization efforts.
3/27: Why brands should get into the weeds on cannabis disinformation
When social media platforms boot legitimate cannabis companies, it leaves more room for other sources of information, not all of which are reliable, says NuggMD’s Alex Milligan.
12/22: States That Restrict Medical Marijuana Qualifying Conditions Are ‘Deterring’ Patients And Compromising Data, Analysis Of 210K+ Records Suggests
A new analysis of a massive dataset of medical marijuana patient records from across the U.S. suggests that states with restrictive eligibility criteria are likely “deterring patients from seeking the medication they need” and compromising access to information on why people use cannabis. Nugg MD, a cannabis technology company that links people to doctors via […]
